Key facts
- This page summarizes Mark A. Johnson's Form 4 filing for Cardlytics, Inc. (CDLX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 May 2022, 20:52.
Mark A. Johnson - 21 May 2022 Form 4 Insider Report for Cardlytics, Inc. (CDLX)
- Reporting relationship
- Director
- Issuer ticker
- CDLX
- Reported as of
- 21 May 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 24 May 2022, 20:52:40 UTC
- Prior SEC filing
- 26 Jan 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kirk L. Somers, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mark A. Johnson filed Form 4 for Cardlytics, Inc. (CDLX) on 24 May 2022.
Change
- Previous filing in this sequence was filed on 26 Jan 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CDLX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +1,701
- Change %
- +4.7%
- Price
- $0.000000
- Shares after
- 37,635
- Date
- 21 May 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CDLX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,701
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 21 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,701
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
Footnote F2
The RSUs vested in full on the one-year anniversary of the date of grant.